Chemotherapy-induced Nausea and Vomiting Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Therapy type (Serotonin receptor antagonists, NK1 receptor antagonists, Dopamine antagonists, Benzodiazepines, Others) and Geography

Report Code: TIPRE00016843 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Chemotherapy-induced nausea and vomiting (CINV) is type of nausea and vomiting caused by cancer drugs dosage. Cancer patient may experience nausea and vomiting within 24 hours (acute type) or after 24 hours (delayed type) of chemotherapy medication. Chemotherapy-induced nausea and vomiting leads to the deferment or refusal of therapeutic chemotherapy treatment for cancer.

MARKET DYNAMICS

Factors driving growth of Chemotherapy-induced Nausea and Vomiting Drugs market during the forecast period are the increasing number of government initiatives in oncology research, rising number of oncology research and development activities, growing incidence of cancer cases, rising adoption of chemotherapy and combination therapy. These are the major factors driving the Chemotherapy-induced Nausea and Vomiting Drugs market.

MARKET SCOPE

The "Global Chemotherapy-induced Nausea and Vomiting Drugs Market Analysis to 2028" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of Chemotherapy-induced Nausea and Vomiting Drugs Market with detailed market segmentation by therapy type and geography. The global Chemotherapy-induced Nausea and Vomiting Drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Chemotherapy-induced Nausea and Vomiting Drugs Market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global Chemotherapy-induced Nausea and Vomiting Drugs Market is segmented on basis of therapy type. Based on therapy type, the global Chemotherapy-induced Nausea and Vomiting Drugs Market is segmented into dopamine antagonists, serotonin receptor antagonists, benzodiazepines, and neurokinin NK1 receptor antagonist.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Chemotherapy-induced Nausea and Vomiting Drugs Market based on various segments. It also provides market size and forecast estimates from year 2019 to2028with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Chemotherapy-induced Nausea and Vomiting Drugs Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Chemotherapy-induced Nausea and Vomiting Drugs Market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Chemotherapy-induced Nausea and Vomiting Drugs Market in these regions.



Get more information on this report :

MARKET PLAYERS


The reports cover key developments in the Chemotherapy-induced Nausea and Vomiting Drugs Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Chemotherapy-induced Nausea and Vomiting Drugs Market are anticipated to lucrative growth opportunities in the future with the rising demand for activated carbon maskin the global market. Below mentioned is the list of fewcompanies engaged in the Chemotherapy-induced Nausea and Vomiting Drugs Market.

The report also includes the profiles of key Chemotherapy-induced Nausea and Vomiting Drugs Market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  GlaxoSmithKline plc
  •  Merck and Co., Inc
  •  Teva Pharmaceuticals
  •  Heron Therapeutics, Inc.
  •  F. Hoffmann-La Roche AG
  •  Tesaro, Inc.
  •  Acacia Pharma
  •  Baxter international Inc.
  •  Lee's Pharmaceutical Holdings
  •  Mundipharma International limited

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Chemotherapy-induced Nausea And Vomiting Drugs Market - By Therapy type
1.3.2 Chemotherapy-induced Nausea And Vomiting Drugs Market - By Region
1.3.2.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING DRUGS - GLOBAL MARKET OVERVIEW
6.2. CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - THERAPY TYPE
7.1. OVERVIEW
7.2. THERAPY TYPE MARKET FORECASTS AND ANALYSIS
7.3. SEROTONIN RECEPTOR ANTAGONISTS
7.3.1. Overview
7.3.2. Serotonin receptor antagonists Market Forecast and Analysis
7.4. NK1 RECEPTOR ANTAGONISTS
7.4.1. Overview
7.4.2. NK1 receptor antagonists Market Forecast and Analysis
7.5. DOPAMINE ANTAGONISTS
7.5.1. Overview
7.5.2. Dopamine antagonists Market Forecast and Analysis
7.6. BENZODIAZEPINES
7.6.1. Overview
7.6.2. Benzodiazepines Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1 North America Chemotherapy-induced Nausea And Vomiting Drugs Market Overview
8.1.2 North America Chemotherapy-induced Nausea And Vomiting Drugs Market Forecasts and Analysis
8.1.3 North America Chemotherapy-induced Nausea And Vomiting Drugs Market Forecasts and Analysis - By Therapy type
8.1.4 North America Chemotherapy-induced Nausea And Vomiting Drugs Market Forecasts and Analysis - By Countries
8.1.4.1 United States Chemotherapy-induced Nausea And Vomiting Drugs Market
8.1.4.1.1 United States Chemotherapy-induced Nausea And Vomiting Drugs Market by Therapy type
8.1.4.2 Canada Chemotherapy-induced Nausea And Vomiting Drugs Market
8.1.4.2.1 Canada Chemotherapy-induced Nausea And Vomiting Drugs Market by Therapy type
8.1.4.3 Mexico Chemotherapy-induced Nausea And Vomiting Drugs Market
8.1.4.3.1 Mexico Chemotherapy-induced Nausea And Vomiting Drugs Market by Therapy type
8.2. EUROPE
8.2.1 Europe Chemotherapy-induced Nausea And Vomiting Drugs Market Overview
8.2.2 Europe Chemotherapy-induced Nausea And Vomiting Drugs Market Forecasts and Analysis
8.2.3 Europe Chemotherapy-induced Nausea And Vomiting Drugs Market Forecasts and Analysis - By Therapy type
8.2.4 Europe Chemotherapy-induced Nausea And Vomiting Drugs Market Forecasts and Analysis - By Countries
8.2.4.1 Germany Chemotherapy-induced Nausea And Vomiting Drugs Market
8.2.4.1.1 Germany Chemotherapy-induced Nausea And Vomiting Drugs Market by Therapy type
8.2.4.2 France Chemotherapy-induced Nausea And Vomiting Drugs Market
8.2.4.2.1 France Chemotherapy-induced Nausea And Vomiting Drugs Market by Therapy type
8.2.4.3 Italy Chemotherapy-induced Nausea And Vomiting Drugs Market
8.2.4.3.1 Italy Chemotherapy-induced Nausea And Vomiting Drugs Market by Therapy type
8.2.4.4 Spain Chemotherapy-induced Nausea And Vomiting Drugs Market
8.2.4.4.1 Spain Chemotherapy-induced Nausea And Vomiting Drugs Market by Therapy type
8.2.4.5 United Kingdom Chemotherapy-induced Nausea And Vomiting Drugs Market
8.2.4.5.1 United Kingdom Chemotherapy-induced Nausea And Vomiting Drugs Market by Therapy type
8.2.4.6 Rest of Europe Chemotherapy-induced Nausea And Vomiting Drugs Market
8.2.4.6.1 Rest of Europe Chemotherapy-induced Nausea And Vomiting Drugs Market by Therapy type
8.3. ASIA-PACIFIC
8.3.1 Asia-Pacific Chemotherapy-induced Nausea And Vomiting Drugs Market Overview
8.3.2 Asia-Pacific Chemotherapy-induced Nausea And Vomiting Drugs Market Forecasts and Analysis
8.3.3 Asia-Pacific Chemotherapy-induced Nausea And Vomiting Drugs Market Forecasts and Analysis - By Therapy type
8.3.4 Asia-Pacific Chemotherapy-induced Nausea And Vomiting Drugs Market Forecasts and Analysis - By Countries
8.3.4.1 Australia Chemotherapy-induced Nausea And Vomiting Drugs Market
8.3.4.1.1 Australia Chemotherapy-induced Nausea And Vomiting Drugs Market by Therapy type
8.3.4.2 China Chemotherapy-induced Nausea And Vomiting Drugs Market
8.3.4.2.1 China Chemotherapy-induced Nausea And Vomiting Drugs Market by Therapy type
8.3.4.3 India Chemotherapy-induced Nausea And Vomiting Drugs Market
8.3.4.3.1 India Chemotherapy-induced Nausea And Vomiting Drugs Market by Therapy type
8.3.4.4 Japan Chemotherapy-induced Nausea And Vomiting Drugs Market
8.3.4.4.1 Japan Chemotherapy-induced Nausea And Vomiting Drugs Market by Therapy type
8.3.4.5 South Korea Chemotherapy-induced Nausea And Vomiting Drugs Market
8.3.4.5.1 South Korea Chemotherapy-induced Nausea And Vomiting Drugs Market by Therapy type
8.3.4.6 Rest of Asia-Pacific Chemotherapy-induced Nausea And Vomiting Drugs Market
8.3.4.6.1 Rest of Asia-Pacific Chemotherapy-induced Nausea And Vomiting Drugs Market by Therapy type
8.4. MIDDLE EAST AND AFRICA
8.4.1 Middle East and Africa Chemotherapy-induced Nausea And Vomiting Drugs Market Overview
8.4.2 Middle East and Africa Chemotherapy-induced Nausea And Vomiting Drugs Market Forecasts and Analysis
8.4.3 Middle East and Africa Chemotherapy-induced Nausea And Vomiting Drugs Market Forecasts and Analysis - By Therapy type
8.4.4 Middle East and Africa Chemotherapy-induced Nausea And Vomiting Drugs Market Forecasts and Analysis - By Countries
8.4.4.1 South Africa Chemotherapy-induced Nausea And Vomiting Drugs Market
8.4.4.1.1 South Africa Chemotherapy-induced Nausea And Vomiting Drugs Market by Therapy type
8.4.4.2 Saudi Arabia Chemotherapy-induced Nausea And Vomiting Drugs Market
8.4.4.2.1 Saudi Arabia Chemotherapy-induced Nausea And Vomiting Drugs Market by Therapy type
8.4.4.3 U.A.E Chemotherapy-induced Nausea And Vomiting Drugs Market
8.4.4.3.1 U.A.E Chemotherapy-induced Nausea And Vomiting Drugs Market by Therapy type
8.5. SOUTH AND CENTRAL AMERICA
8.5.1 South and Central America Chemotherapy-induced Nausea And Vomiting Drugs Market Overview
8.5.2 South and Central America Chemotherapy-induced Nausea And Vomiting Drugs Market Forecasts and Analysis
8.5.3 South and Central America Chemotherapy-induced Nausea And Vomiting Drugs Market Forecasts and Analysis - By Therapy type
8.5.4 South and Central America Chemotherapy-induced Nausea And Vomiting Drugs Market Forecasts and Analysis - By Countries
8.5.4.1 Brazil Chemotherapy-induced Nausea And Vomiting Drugs Market
8.5.4.1.1 Brazil Chemotherapy-induced Nausea And Vomiting Drugs Market by Therapy type
8.5.4.2 Argentina Chemotherapy-induced Nausea And Vomiting Drugs Market
8.5.4.2.1 Argentina Chemotherapy-induced Nausea And Vomiting Drugs Market by Therapy type
9. IMPACT OF COVID-19 PANDEMIC ON GLOBAL CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING DRUGS MARKET
9.1 North America
9.2 Europe
9.3 Asia-Pacific
9.4 Middle East and Africa
9.5 South and Central America
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING DRUGS MARKET, KEY COMPANY PROFILES
11.1. GLAXOSMITHKLINE PLC
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. MERCK AND CO., INC
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. TEVA PHARMACEUTICALS
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. HERON THERAPEUTICS, INC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. F. HOFFMANN-LA ROCHE AG
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. TESARO, INC.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. ACACIA PHARMA
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. BAXTER INTERNATIONAL INC.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. LEE'S PHARMACEUTICAL HOLDINGS
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. MUNDIPHARMA INTERNATIONAL LIMITED
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. GlaxoSmithKline plc
2. Merck and Co., Inc
3. Teva Pharmaceuticals
4. Heron Therapeutics, Inc.
5. F. Hoffmann-La Roche AG
6. Tesaro, Inc.
7. Acacia Pharma
8. Baxter international Inc.
9. Lee's Pharmaceutical Holdings
10. Mundipharma International limited
TIPRE00016843
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking